Pediatric Pharmacy
PGY2 Program Purpose: PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Description
The University of Oklahoma College of Pharmacy (OUCOP) and OU Health has been accredited with the American Society of Health System Pharmacists (ASHP) since 2005 and currently offers position each year. Our program is approved to offer the traditional PGY2 Pediatrics and the PGY2 Pediatrics with added Critical Care with Specialty Pathway (PSP).
This one-year position provides the resident with the academic rank of Clinical Instructor with the University of Oklahoma College of Pharmacy (OUCOP). The residents are primarily involved in clinical practice at Oklahoma Children's Hospital at OU Health. Educational responsibilities and training include didactic (lecture) and experiential (rotation) teaching to Pharm.D. students in addition to other activities. Residents contribute to the education of pharmacy students, resident physicians, medical students, faculty physicians, and other members of the healthcare team. PGY2 residents will participate in teaching sessions, deliver at least 2 formal presentations, and serve as preceptor of record for APPE students during one learning experience. PGY2 residents have the option to receive an advanced teaching and precepting skills certificate through completion of additional requirements. In addition, the resident will be required to complete an original research project for completion of the residency program; they will be expected to present their research at national meetings and will be encouraged to publish their findings.
Outcomes
PGY2 Pediatric residents are expected to achieve 80% of these educational outcomes from the required ASHP PGY2 Pediatric Residency competency, areas, goals, and objectives (CAGOS). The remaining 20% must be assessed at a minimum of satisfactory progress. These include the objectives under the five required competency areas (R1-patient care, R2-advancing practice and improving patient care, R3-leadership and management, R4- teaching/education/dissemination of knowledge, RS-management of medical emergencies) as well as the objectives under two of the elective competency areas (E4-added skills for pediatric pharmacy scholarship).
In addition to this, residents are also expected to document coverage of the required pediatric disease states listed at the end of the ASHP Educational Outcomes, Goals, and Objectives for PGY2 Pediatric Pharmacy residents.
Practice Site
The Downtown Campus of OU Health in Oklahoma City is comprised of two hospitals: Oklahoma Children’s Hospital at OU Health and University of Oklahoma Medical Center. Oklahoma Children’s Hospital at OU Health is a 336-bed teaching hospital with a 106-bed Neonatal ICU, a 34-bed Medical ICU, and a 25-bed Cardiovascular ICU (CICU). It is the only comprehensive children's hospital in the state of Oklahoma.
PGY2 Pediatrics Rotation Requirements
-
Residents are required to complete 12, one-month calendar rotations.
- Orientation
- General Pediatrics I
- PICU I
- NICU I
- Selective rotation in NICU or CICU (Resident must complete an additional rotation in one of these areas)
- Inpatient hematology/oncology
- CICU I
- Research
*During the Selective rotation, the resident will serve as the primary preceptor for 2 APPE students.
-
Residents select 4 electives
- Clinical toxicology/poison control
- Infectious disease
- Nephrology
- Outpatient hematology/oncology
- Emergency medicine
- Other*
*May also elect to repeat one to the required rotations as above.
-
Unless other specified below, residents complete these longitudinal rotations from July through June each academic year.
- Research
- Staffing
- Teaching
- Ambulatory Care (1 half-day per week, August-June)
- Management
PGY2 Pediatrics with Added Critical Care PSP Designation Status (Recruiting in academic year 2026-2027)
-
Residents are required to complete 12, one-month calendar rotations.
- Orientation (July)
- General Pediatrics*
- Inpatient hematology/oncology
- PICU I
- NICU I
- NICU II*
- CICU I*
- Research
- Clinical toxicology
*During one of these core rotations, the resident will serve as the primary preceptor for 2 APPE students under the director of one of our faculty-based preceptors.
-
Residents must complete 2 of the following rotations.
- PICU II
- CICU II
- Emergency medicine
- NICU III
-
Residents must complete 1 additional elective.
- Nephrology
- Infectious disease
- Out-patient hematology/oncology
- Emergency medicine
- Other (May also elect to repeat one of the required or critical care selective rotations as above)
-
Unless other specified below, residents complete these longitudinal rotations from July through June each academic year.
- Research
- Staffing
- Teaching
- Management
Other Requirements and Opportunities
-
The resident delivers at a minimum of two lectures to Pharm.D. students and other interprofessional learners throughout the year. Teaching also occurs throughout the year as the resident presents interdisciplinary in services to the medical and nursing staff and assists with precepting of Pharm.D. students in the experiential portion of their curriculum. The resident assumes primary precepting responsibility for P4 students during the latter part of the residency.
-
Residents complete a research curriculum which includes the University of Oklahoma Health Campus Institutional Review Board (IRB) certification for conducting human research and specific research training sessions through Resident Rounds. Each resident designs and executes an original research project under the mentorship of their research committee, which consists of the residency program director, an expert in the practice area in which research will be conducted, and an expert in study design, data analysis, and statistical methods. Residents present preliminary research findings during a podium presentation at the Pediatric Pharmacy Association Annual Meeting and the Oklahoma Pharmacy Residency Conference. In accordance with ASHP standards, residents prepare a high-quality manuscript based on their research findings.
-
The resident participates in the peer-review of at least two manuscripts submitted for publication. The resident is also expected to contribute to the literature through preparation and publication of a newsletter article, a case report or review article, and their original research.
-
The resident develops practice management skills through participation in institutional projects and committee work at The Oklahoma Children’s Hospital at OU Health. In addition, the resident develops their leadership philosophy through readings and discussions with the leadership preceptor and one-on-one meetings with local pharmacy leaders.
-
Professional Organization Involvement
Resident involvement in local and national professional organizations (as their residency schedule allows) is encouraged. Examples include:
- Oklahoma Society of Health-System Pharmacists (OSHP)
- American Society of Health-System Pharmacists (ASHP)
- American College of Clinical Pharmacy (ACCP)
- American Association of Colleges of Pharmacy (AACP)
- Pediatric Pharmacy Association (PPA)
University of Oklahoma College of Pharmacy Committees
Resident involvement in college committees is also encouraged. Examples include:
- One academic committee to support the College
- Other meetings based on resident interests
Program Requirements Checklist & Structure
PGY2 Pediatrics Residency Program Requirements Checklist (2026-2027)
PGY2 Pediatrics with an Added Critical Care PSP Designation Status Program Requirements Checklist (2026-2027)
PGY2 Pediatrics & PGY2 Pediatrics PSP Critical Care Residency Program Structure (2026-2027)
Residency Program Director
Peter N. Johnson, Pharm.D., BCPPS, FPPA, FCCM, FASHP
Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: CICU and PICU (back-up coverage)
Residency Program Preceptors
Ashley Benedict, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: General pediatrics.
Whitney Bueno, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Outpatient ambulatory care in hematology and oncology.
Jennifer Dannelley, Pharm.D. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: Outpatient ambulatory care in cystic fibrosis, pulmonology.
Erica Fuchs, Pharm.D., BCPPS. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: NICU
Elisabeth Kneeeland, Pharm.D. Clinical Pharmacy Manager, Oklahoma Children’s hospital at OU Health. Practice area; Practice management.
Jennifer Le, Pharm.D., BCPPS. Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Inpatient hematology and oncology, stem cell transplant.
Teresa V. Lewis, Pharm.D., BCPS. Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Nephrology, renal transplant, and inpatient general pediatrics.
Jamie Miller, Pharm.D., BCPPS, FPPA, FASHP. Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: NICU.
Andrea Nguyen, Pharm.D. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: Maternal Fetal Medicine and antimicrobial Stewardship
Eszter Moore, Pharm.D., CSPI. Certified specialist in Poison Information, Oklahoma Poison Center. Practice area: Toxicology.
Natalie Nix, Pharm.D. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: PICU.
Misty Oldham, Pharm.D., BCPS, AAHIVP. Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Outpatient HIV and inpatient infectious disease.
Avery Parman, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Emergency medicine.
Katy Stephens, Pharm.D., BCPPS. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: CICU and cardiac transplant.
Current Residents
Mackenzie Luke, Pharm.D. (2025-2026); PGY1 – University of Oklahoma College of Pharmacy/OU Health; Oklahoma City, OK and Doctor of Pharmacy – University of Houston College of Pharmacy; Houston, TX
Research Project: Evaluation of aminophyine for prevention and treatment of acute kidney injury in critically ill pediatric patients in the cardiac intensive
-
| Resident
| Residency Year
|
| Natalie Nix, Pharm.D.
| 2024-2025
|
| Avery Parman, Pharm.D.
| 2023-2024
|
| Eugenie Chang, Pharm.D.
| 2022-2023
|
| Caitlyn Bradford, Pharm.D.
| 2021-2022
|
| Katy Stephens, Pharm.D.
| 2020-2021
|
| Khalid Taher, Pharm.D.
| 2020-2021
|
| Maura (Harkin) Shrestha, Pharm.D.
| 2019-2020
|
| Brittany Powers-Shaddix, Pharm.D.
| 2018-2019
|
| Amy Nguyen, Pharm.D.
| 2016-2017
|
| Amanda Capino, Pharm.D.
| 2015-2016
|
| Katlyn (Katie) Hughes, Pharm.D.
| 2014-2015
|
| Bethany Ibach, Pharm.D.
| 2013-2014
|
| Megan (Andrews) Carroll, Pharm.D.
| 2012-2013
|
| Erin (Lammers) Martin, Pharm.D.
| 2011-2012
|
| Misty (Miller) Oldham, Pharm.D.
| 2010-2011
|
| Emily (Gish) Benefield, Pharm.D.
| 2009-2010
|
| Brooke (Honey) Gildon, Pharm.D.
| 2008-2009
|
| Jamie Miller, Pharm.D.
| 2007-2008
|
| Teresa Lewis, Pharm.D.
| 2004-2005
|
Accreditation
This residency program is accredited by the American Society of Health-System Pharmacists.